Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Lexicon Pharmaceuticals Received Notice Of 180-Calendar Day Extension To Regain Nasdaq Compliance

Author: Benzinga Newsdesk | July 03, 2025 09:14am

https://www.sec.gov/ix?doc=/Archives/edgar/data/1062822/000106282225000035/lxrx-20250703.htm

Posted In: LXRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist